Argent Biopharma Ltd

Company Profile

• Business description

  Argent Biopharma Ltd is a revenue-generating, clinical-stage biopharmaceutical company focused on the development and commercialization of nano-engineered therapeutics targeting neurological and immunemediated disorders. Its assets, CannEpil and CimetrA, are for drug-resistant epilepsy and inflammatory conditions, respectively. The company leverages proprietary nano-delivery technologies designed to optimize bioavailability and tissue penetration, including across the blood-brain barrier and pulmonary interfaces. The company operates in a single segment. Geographically, it operates in Malta, Slovenia, UK, and Australia, with the majority of revenue deriving from Slovenia.

• Contact

  295 Rokeby Road
  Suite 1
  SubiacoWA6008
  AUS

  T: +61 865552950

  E: [email protected]

  https://www.argentbiopharma.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Drug Manufacturers - Specialty & Generic

  Fiscal Year End

  Employees